Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/121172
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | The β-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial |
| Other Titles: | The beta-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial |
| Author: | Roberts, M.A. Pilmore, H.L. Ierino, F.L. Badve, S.V. Cass, A. Garg, A.X. Isbel, N.M. Krum, H. Pascoe, E.M. Perkovic, V. Scaria, A. Tonkin, A.M. Vergara, L.A. Hawley, C.M. Levin, A. Hare, D. Martin, A. Wheeler, D.C. Fulcher, G. Brown, H. et al. |
| Citation: | American Journal of Kidney Diseases, 2016; 67(6):902-911 |
| Publisher: | Elsevier; Clinical Key |
| Issue Date: | 2016 |
| ISSN: | 0272-6386 1523-6838 |
| Statement of Responsibility: | Matthew A. Roberts … Robert P. Carroll, Eileen Scott … et al. (on behalf of the BLOCADE Study Collaborative Group) |
| Abstract: | Abstract not available |
| Keywords: | Beta-blocker; carvedilol; Dilatrend; adrenergic receptor blockade; dialysis; hemodialysis; cardiovascular disease (CVD); cardiovascular mortality; intradialytic hypotension (IDH); bradycardia; feasibility study; study recruitment; drug tolerability; randomized controlled trial (RCT); end-stage kidney disease (ESKD) |
| Rights: | © 2016 by the National Kidney Foundation, Inc. |
| DOI: | 10.1053/j.ajkd.2015.10.029 |
| Grant ID: | http://purl.org/au-research/grants/nhmrc/1006171 http://purl.org/au-research/grants/nhmrc/628902 |
| Published version: | http://dx.doi.org/10.1053/j.ajkd.2015.10.029 |
| Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.